Page last updated: 2024-09-05

erlotinib hydrochloride and Thromboembolism

erlotinib hydrochloride has been researched along with Thromboembolism in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amarshi, N; Billingsley, A; Nair, BA; Thomas, KS1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Thromboembolism

ArticleYear
Elevated international normalized ratio associated with concomitant warfarin and erlotinib.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Sep-01, Volume: 67, Issue:17

    Topics: Adenocarcinoma; Anticoagulants; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; International Normalized Ratio; Lung Neoplasms; Male; Middle Aged; Quinazolines; Thromboembolism; Warfarin

2010